Autoreactive T cells in Systemic Lupus Erythematosus - Abdirama, Dimas
61,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disorder characterized by loss of immune tolerance towards nuclear autoantigens such as SmD1, RNP70, Histone, Ro, and La. Although great progress towards our understanding of the disease has been made over the past 50 years and mortality is currently only around 10% within the last ten years, our knowledge of the factors that drive the pathology of SLE is still limited. The role of CD4+ T cells specific to nuclear antigens in the disease pathogenesis of SLE is yet not fully known because the detection of human autoreactive…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disorder characterized by loss of immune tolerance towards nuclear autoantigens such as SmD1, RNP70, Histone, Ro, and La. Although great progress towards our understanding of the disease has been made over the past 50 years and mortality is currently only around 10% within the last ten years, our knowledge of the factors that drive the pathology of SLE is still limited. The role of CD4+ T cells specific to nuclear antigens in the disease pathogenesis of SLE is yet not fully known because the detection of human autoreactive CD4+ T cells has been extremely challenging. In this book, the author Dimas Abdirama describes how autoreactive CD4+ T cell subsets participate in autoimmunity. The book provides insight into previously unrecognized pathogenic characteristics of autoreactive CD4+ T cells in SLE, expanding our knowledge in human systemic autoimmune disease.
Autorenporträt
Dr.-Ing. Dimas Abdirama, born in Jakarta, 1986, graduated in medical biotechnology and received his doctoral degree from Technische Universität Berlin for his work in immunology. He works as a postdoctoral researcher at Charité - Universitätsmedizin Berlin and as an independent auditor for food, pharmaceutical, and biotech industry within Europe.